[CL2-95011-001]-Laysummary-2023.11.08.EN

Home » A phase IIa efficacy and safety trial with intravenous S95011 in primary Sjögren’s Syndrome patients. An international, multicentre, randomised, double-blind, placebo-controlled study. » [CL2-95011-001]-Laysummary-2023.11.08.EN

© 2024 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.

Accessibility